The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy

被引：0
|
作者：
Sen, Saniye
Ustundag, Sedat
Gonlusen, Gulfiliz
Kanter, Mehmet
Dogutan, Haluk
Ciftci, Senturk
机构：
[1] Trakya Univ, Fac Med, Edirne, Turkey
[2] Cukurova Univ, Fac Med, Adana, Turkey
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [32] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [33] Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Wang, Gang
    Lai, Fernand Mac-Moune
    Lai, Ka-Bik
    Chow, Kai-Ming
    Kwan, Bonnie Ching-Ha
    Li, Philip Kam-Tao
    Szeto, Cheuk-Chun
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (03) : 317 - 322
  • [34] Effects of an angiotensin-converting enzyme inhibitor and a β-blocker on cerebral arterioles in rats
    Chillon, JM
    Baumbach, GL
    HYPERTENSION, 1999, 33 (03) : 856 - 861
  • [35] Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker
    Portilla, Alfredo
    Torres, Daniel
    Enrique Machado-Duque, Manuel
    Enrique Machado-Alba, Jorge
    ATENCION PRIMARIA, 2016, 48 (04): : 272 - 274
  • [36] Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison
    Roberto Robles, Nicolas
    Romero, Baldomero
    Fernandez-Carbonero, Enrique
    Sanchez-Casado, Emilio
    Jose Cubero, Juan
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2009, 10 (04) : 195 - 200
  • [37] Dual beneficial effect of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in diabetic nephropathy
    Ljubic, S
    Bozikov, J
    Kljajlc, K
    Pavlic-Renar, I
    Vucic-Lovrencic, M
    Metelko, Z
    DIABETES, 2005, 54 : A199 - A199
  • [38] Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy
    Anantharaman, R.
    Bhansali, Anil
    Bhadada, Sanjay K.
    Kohli, Harbir S.
    Dutta, Pinaki
    Walia, Rama
    Jayaprakash, P.
    Upreti, Vimal
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (01) : 42 - 47
  • [39] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND DIABETIC NEPHROPATHY
    BEAUFILS, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S33 - S38
  • [40] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN DIABETIC NEPHROPATHY
    BREYER, JA
    HUNSICKER, LG
    BAIN, RP
    LEWIS, EJ
    KIDNEY INTERNATIONAL, 1994, 45 : S156 - S160
12345